FDA permits experimental use of Iplex on ALS patients

03/11/2009 | Reuters

The FDA said it is allowing selected patients with Lou Gehrig's disease to use Iplex, Insmed's treatment for growth-hormone deficiency, as the company awaits the conclusion of a patent-infringement case that put sales on hold. Insmed plans to use part of its "very limited" supply of Iplex to conduct safety trials.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT